Healthcare Sales & Marketing Network News: Solvay Pharmaceuticals

Searching News Database: Solvay Pharmaceuticals

HSMN NewsFeed - 19 Dec 2017
Disarm Therapeutics Appoints Peter Keller Chief Business Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 26 Oct 2017
Intec Pharma Names Walt Linscott as Chief Administrative Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 10 Feb 2016
Amarantus Receives Orphan Drug Designation From the US FDA for Eltoprazine in the Treatment of Parkinson's Disease Levodopa-Induced Dyskinesia
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 4 Jan 2016
Ardelyx Strengthens Executive Leadership Team with the Appointment of Paul Korner, MD, MBA, as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Gastroenterology Personnel

HSMN NewsFeed - 8 Sep 2015
Selecta Biosciences Appoints Earl E. Sands, MD, as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jan 2014
Lipocine Announces New Appointments to Its Board of Directors
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 11 Nov 2013
Aprecia Welcomes Don Wetherhold as Its Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Apr 2013
David A. Dodd Appointed President & Chief Executive Officer of Aeterna Zentaris Inc.
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Jan 2013
Galectin Therapeutics Appoints Industry Veteran Rex Horton as Executive Director of Regulatory Affairs and Quality Assurance
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 15 Nov 2012
Targacept Appoints Stephen A. Hill, M.D., President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 27 Oct 2010
Laurence J. Downey, MD Joins Arbor Pharmaceuticals as Vice President of Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Aug 2010
Selecta Biosciences Appoints Werner Cautreels, Ph.D., as Company's First CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Aug 2010
Watson Plans Q4 2010 ella(R) (ulipristal acetate) Emergency Contraceptive Launch
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jun 2010
Eurand Names Former Solvay Executive Jean-Louis Anspach President of U.S. Pharmaceuticals Business
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 May 2010
Abbott to Become No. 1 Pharmaceutical Company in India with Acquisition of Piramal's Healthcare Solutions Business
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 11 May 2010
Abbott Accelerates Emerging Markets Pharmaceutical Leadership With Zydus Cadila Collaboration; Separately Creates Stand-Alone Established Products Division
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Apr 2010
AcelRx Pharmaceuticals Names Richard King Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 4 Mar 2010
Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 16 Feb 2010
Abbott Completes Acquisition of Solvay Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 Feb 2010
Watson and HRA Pharma Announce Exclusive Licensing Agreement to Commercialize Novel Emergency Contraceptive in the U.S.
Biopharmaceuticals Licensing

HSMN NewsFeed - 28 Jan 2010
Lupin Receives U.S. FDA Approval For Perindopril Erbumine Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 9 Dec 2009
New Published Data Demonstrate Long-Term Safety, Efficacy and Tolerability of Watson's RAPAFLO(R) (silodosin) for Benign Prostatic Hyperplasia (BPH) Symptom Relief
Biopharmaceuticals Urology

HSMN NewsFeed - 2 Dec 2009
AMT Announces Management Changes in Light of Refocused Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Nov 2009
Depomed Files Patent Infringement Lawsuit Against Lupin Limited
Biopharmaceuticals Generics Litigation FDA

HSMN NewsFeed - 18 Nov 2009
Depomed Promotes William Callahan to Vice President of Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Nov 2009
Depomed Receives Notice of Paragraph IV Certification Against Patents for GLUMETZA(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 28 Sep 2009
Abbott to Acquire Solvay Pharmaceuticals Business
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 1 Jun 2009
Depomed Names Shay Weisbrich Vice President of Marketing
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 21 May 2009
Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
Biopharmaceuticals Urology

HSMN NewsFeed - 8 May 2009
RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days
Biopharmaceuticals Urology

HSMN NewsFeed - 7 Apr 2009
Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
Biopharmaceuticals Urology

HSMN NewsFeed - 2 Feb 2009
Federal Trade Commission Files Complaint Against Par Pharmaceutical Over Court-Approved AndroGel(R) Litigation Settlement
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 2 Feb 2009
Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 27 Jan 2009
Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
Biopharmaceuticals Drug Delivery Urology FDA

HSMN NewsFeed - 5 Jan 2009
Depomed Announces Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Oct 2008
Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH)
Biopharmaceuticals FDA Urology

HSMN NewsFeed - 18 Aug 2008
Somaxon Pharmaceuticals Announces the Appointment of Senior Commercial Leadership
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jul 2008
Gen-Probe Does Not Intend to Increase Offer to Acquire Innogenetics
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 3 Jun 2008
Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 21 May 2008
Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
Biopharmaceuticals Urology

HSMN NewsFeed - 14 Apr 2008
Jazz Pharmaceuticals' LUVOX CR Is Now Available for Patients With Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
Biopharmaceuticals

HSMN NewsFeed - 29 Feb 2008
Tercica Announces Changes to Its Board of Directors and Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Feb 2008
Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
Biopharmaceuticals

HSMN NewsFeed - 28 Feb 2008
FDA Approves LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Feb 2008
Solvay Pharmaceuticals, Inc. Receives Fast Track Designation From U.S. Food and Drug Administration for Levodopa/Carbidopa Intestinal Gel for Advanced Parkinson's Disease
Biopharmaceuticals FDA Neurology

HSMN NewsFeed - 30 Jan 2008
Stephen Hill, ArQule President and CEO, to Join Solvay Pharmaceuticals, Inc. as New President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jan 2008
Solvay Pharmaceuticals, Inc. Announces Retirement of CEO Laurence Downey and Appointment of Stephen Hill as New President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jan 2008
Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
Biopharmaceuticals Urology

HSMN NewsFeed - 21 Dec 2007
FDA Issues Approvable Letter for LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Dec 2007
Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
Biopharmaceuticals Cardiology

HSMN NewsFeed - 5 Dec 2007
Edward J. Schutter Appointed to President and Chief Operating Officer of Sciele Pharma, Inc.
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Nov 2007
Cumberland Pharmaceuticals Announces Senior Management Promotions
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Aug 2007
Dr. Garratt W. Ponder Named Vice President of Pharmaceutical Development for Atlanta-Based Tikvah Therapeutics, Inc.
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Aug 2007
Solvay Pharmaceuticals, Inc. Receives Approvable Letter from FDA with Respect to New Drug Application for CREON(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Aug 2007
Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Aug 2007
Wyeth Pharmaceuticals and Solvay Pharmaceuticals, Inc. Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Jul 2007
Agile Therapeutics Appoints Dr. Marie Foegh as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 May 2007
AEterna Zentaris Regains Exclusive Worldwide (ex-Japan) Rights from Solvay for Cetrorelix in Endometriosis Indication
Biopharmaceuticals

HSMN NewsFeed - 30 Mar 2007
Safety Analyses of Clinical Data for Bifeprunox in Patients with Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar to Placebo
Biopharmaceuticals

HSMN NewsFeed - 6 Mar 2007
Jury Finds in Favor of ETHEX/KV on All Claims Against KV Pharmaceutical and ETHEX Subsidiary
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 28 Feb 2007
Tercica Announces the Appointment of Richard A. King as Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Feb 2007
Jazz Pharmaceuticals, Inc. and Solvay Pharmaceuticals, Inc. Announce License Agreement for LUVOX(R) (Fluvoxamine Maleate) Tablets and Fluvoxamine Maleate Extended-Release Capsules in the United States
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Dec 2006
Bifeprunox Showed Improvement of Symptoms and Maintenance of Stability with Fewer Metabolic Side Effects vs. Placebo in Patients with Schizophrenia
Biopharmaceuticals

HSMN NewsFeed - 6 Dec 2006
Phase 2 and 3 Clinical Data for Bifeprunox in Patients With Schizophrenia Showed Improvement of Symptoms and Maintenance of Stability With Fewer Metabolic Side Effects Versus Placebo
Biopharmaceuticals

HSMN NewsFeed - 4 Dec 2006
New Atlanta-Based Pharmaceutical Company Focuses on Central Nervous System
Biopharmaceuticals Neurology

HSMN NewsFeed - 6 Nov 2006
Abbott to Expand Presence in Lipid Management Market With Acquisition of Kos Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 11 Oct 2006
CV Therapeutics Ending Co-Promotion of ACEON(R) (perindopril erbumine) Tablets
Biopharmaceuticals

HSMN NewsFeed - 20 Sep 2006
ProEthic Pharmaceuticals Promotes Roger Graben to Vice President, Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Sep 2006
Watson and Unimed Pharmaceuticals, Inc. Settle Lawsuit Over AndroGel(R) Testosterone Gel
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 13 Sep 2006
Unimed Pharmaceuticals, Inc. Settles AndroGel(R) Litigation with Watson Pharmaceuticals, Inc. and Paddock Laboratories/Par Pharmaceutical Companies, Inc.
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 13 Sep 2006
Par Pharmaceutical Announces Agreement With Unimed Pharmaceuticals to Settle AndroGel(R) Patent Litigation
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 11 Jul 2006
Solvay Pharmaceuticals Settles Lawsuit Against Pseudo-Generic to CREON(R) MINIMICROSPHERES(R)
Biopharmaceuticals Litigation

HSMN NewsFeed - 5 Jul 2006
Abbott and AstraZeneca Announce Collaboration to Develop and Commercialize CRESTOR(R) and Next-Generation TriCor(R) (ABT-335) Fixed-Dose Combination
Biopharmaceuticals Cardiology

HSMN NewsFeed - 29 Jun 2006
IMPAX Settles Solvay Litigation
Biopharmaceuticals Litigation

HSMN NewsFeed - 30 May 2006
Stiefel Laboratories Appoints Jim Loerop, Vice President U.S. Corporate Development
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 43

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 43 additional stories matching:
Solvay Pharmaceuticals
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.